Collagen Matrix, Inc. Selected to Participate in FDA’s Experiential Learning Program

Collagen Matrix, Inc., a leading provider of high quality products and technology used in tissue repair and regeneration announced today it has been selected to participate in the Food and Drug Administration’s Experiential Learning Program (ELP).  The ELP is designed to provide the FDA’s Center for Devices and Radiological Health (CDRH) review staff with real-world…

Read More

Collagen Matrix, Inc. Completes Transaction with Metalmark Capital

Collagen Matrix, Inc., a leading provider of high quality products and technology used in tissue repair and regeneration, today announced the completion of a majority investment by Metalmark Capital, a New York-based private equity firm. Metalmark’s investment in Collagen Matrix will provide the resources, expertise and capital needed to continue to grow the business. As…

Read More

Collagen Matrix, Inc. Receives FDA 510(k) Clearance of a Flexible Collagen Nerve Conduit for Reduction of Painful Neuroma Formation

Collagen Matrix, Inc. announced today that it has received FDA’s 510(k) clearance of its Flexible Collagen Nerve Conduit for management of peripheral nerve injuries at nerve ends in the foot to reduce the formation of painful neuroma. This is the first and only nerve conduit to receive FDA clearance for treatment of neuroma formation at…

Read More

Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Selected and Inducted into the New Jersey Inventors Hall of Fame

Collagen Matrix’s Shu-Tung Li Honored by Inventors Hall of Fame Shu-Tung Li, Ph.D., the founder and CEO of Collagen Matrix, Inc. was a 2012 inductee into the New Jersey Inventors Hall of Fame. The award is co-sponsored by the Stevens Institute of Technology and Greenberg Traurig, LLP. The recognition is for Li’s “Patented technology related…

Read More